Ana Campar

877 total citations
19 papers, 260 citations indexed

About

Ana Campar is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Ana Campar has authored 19 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Rheumatology. Recurrent topics in Ana Campar's work include Glycosylation and Glycoproteins Research (5 papers), Galectins and Cancer Biology (4 papers) and Salivary Gland Disorders and Functions (3 papers). Ana Campar is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Galectins and Cancer Biology (4 papers) and Salivary Gland Disorders and Functions (3 papers). Ana Campar collaborates with scholars based in Portugal, United Kingdom and United States. Ana Campar's co-authors include Inês Alves, Salomé S. Pinho, Carlos Vasconcelos, David Isenberg, Manuel M. Vicente, Vanda Pinto, Ana M. Dias, Ângela Fernandes, Márcia S. Pereira and Jorge Braga and has published in prestigious journals such as SHILAP Revista de lepidopterología, Science Translational Medicine and Frontiers in Immunology.

In The Last Decade

Ana Campar

17 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Campar Portugal 8 134 124 67 34 25 19 260
Nadine Landolina Italy 11 67 0.5× 178 1.4× 40 0.6× 88 2.6× 32 1.3× 22 302
Natalia Mercer United States 8 138 1.0× 51 0.4× 24 0.4× 19 0.6× 16 0.6× 13 266
Y. Date Japan 6 59 0.4× 216 1.7× 51 0.8× 21 0.6× 25 1.0× 9 345
Sooghee Chang United States 10 74 0.6× 221 1.8× 114 1.7× 18 0.5× 9 0.4× 13 347
Alex Kudrin South Korea 10 47 0.4× 215 1.7× 32 0.5× 43 1.3× 16 0.6× 14 309
Maria I. Edilova Canada 5 120 0.9× 135 1.1× 95 1.4× 10 0.3× 12 0.5× 6 310
F Hasler United States 5 148 1.1× 87 0.7× 121 1.8× 23 0.7× 20 0.8× 8 343
Øystein Eikrem Norway 10 170 1.3× 30 0.2× 18 0.3× 60 1.8× 20 0.8× 30 295
Zhiyong Lu China 7 99 0.7× 119 1.0× 11 0.2× 41 1.2× 11 0.4× 11 252
Stephanie Jeong United States 7 174 1.3× 40 0.3× 25 0.4× 42 1.2× 14 0.6× 9 326

Countries citing papers authored by Ana Campar

Since Specialization
Citations

This map shows the geographic impact of Ana Campar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Campar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Campar more than expected).

Fields of papers citing papers by Ana Campar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Campar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Campar. The network helps show where Ana Campar may publish in the future.

Co-authorship network of co-authors of Ana Campar

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Campar. A scholar is included among the top collaborators of Ana Campar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Campar. Ana Campar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Campar, Ana, et al.. (2023). Aortic dissection in a patient with novel frameshift COL5A1 variant of classical Ehlers-Danlos syndrome. European Journal of Case Reports in Internal Medicine. 10(2). 3698–3698. 1 indexed citations
2.
Campar, Ana, et al.. (2023). Idiopathic inflammatory myopathies – The burden of disease: Cohort analysis focusing on damage and comorbidities. Autoimmunity Reviews. 22(12). 103455–103455. 8 indexed citations
3.
Alves, Inês, Ana Campar, Vanda Pinto, et al.. (2023). Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunity. Science Translational Medicine. 15(687). eabo1930–eabo1930. 27 indexed citations
4.
Campar, Ana, et al.. (2023). Muscle glycome in idiopathic inflammatory myopathies: Impact in IL-6 production and disease prognosis. iScience. 26(7). 107172–107172. 2 indexed citations
5.
Marinho, António, José Delgado Alves, Raquel Faria, et al.. (2023). Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren’s syndrome: evidence- and practice-based guidance. Frontiers in Immunology. 14. 1117699–1117699. 24 indexed citations
6.
Crespo, Jorge, Fernando Salvador, José Delgado Alves, et al.. (2023). Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance. Autoimmunity Reviews. 22(8). 103362–103362.
7.
Damásio, Joana, et al.. (2022). Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection. The Neurohospitalist. 12(2). 383–387. 1 indexed citations
8.
Alves, Inês, Manuel M. Vicente, Ana M. Dias, et al.. (2021). The Role of Glycosylation in Inflammatory Diseases. Advances in experimental medicine and biology. 1325. 265–283. 6 indexed citations
9.
Alves, Inês, Hans Dalebout, Manuel M. Vicente, et al.. (2021). Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 73(11). 2069–2077. 27 indexed citations
10.
Lamas, Nuno Jorge, et al.. (2021). Immunoglobulin G4 Related-Disease: A Rare Presentation With Secondary Hypereosinophilic Syndrome and Eosinophilic Ascites. Journal of Medical Cases. 12(3). 107–111. 1 indexed citations
11.
Carvalheiras, Graziela, et al.. (2021). Biologics Drugs in Behçet’s Disease: A Single Centre Experience. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 28(4). 1 indexed citations
12.
Alves, Inês, Vanda Pinto, Ana Campar, et al.. (2020). AB0123 CHANGES IN CELLULAR GLYCOSYLATION AS A KEY FACTOR IN THE IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 79. 1361–1362. 2 indexed citations
13.
Brandão, Mariana, Raquel Faria, Ana Campar, et al.. (2020). P117 Rituximab therapy for primary Sjögren’s syndrome – a retrospective single-centre study. Poster presentations. A85.2–A85. 1 indexed citations
14.
Campar, Ana, et al.. (2020). Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports. SHILAP Revista de lepidopterología. 7(Vol 7 No 4). 1485–1485. 5 indexed citations
15.
Pereira, Márcia S., Inês Alves, Manuel M. Vicente, et al.. (2018). Glycans as Key Checkpoints of T Cell Activity and Function. Frontiers in Immunology. 9. 2754–2754. 102 indexed citations
16.
Campar, Ana, et al.. (2018). Association of severe and therapy-refractory systemic lupus erythematosus and neuromyelitis optica: a management challenge. BMJ Case Reports. 2018. bcr–2017. 2 indexed citations
17.
Braga, Jorge & Ana Campar. (2016). [Biological causes of depression in Systemic Lupus Erythematosus].. PubMed. 39(3). 218–26. 11 indexed citations
18.
Campar, Ana, Fátima Farinha, & Carlos Vasconcelos. (2011). Refractory disease in Systemic Lupus Erythematosus. Autoimmunity Reviews. 10(11). 685–692. 15 indexed citations
19.
Campar, Ana & David Isenberg. (2010). Primary Sjögren’s syndrome activity and damage indices comparison. European Journal of Clinical Investigation. 40(7). 636–644. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadine Landolina Breakdown of academic impact, for papers by Natalia Mercer Breakdown of academic impact, for papers by Y. Date Breakdown of academic impact, for papers by Sooghee Chang Breakdown of academic impact, for papers by Alex Kudrin Breakdown of academic impact, for papers by Maria I. Edilova Breakdown of academic impact, for papers by F Hasler Breakdown of academic impact, for papers by Øystein Eikrem Breakdown of academic impact, for papers by Zhiyong Lu Breakdown of academic impact, for papers by Stephanie Jeong
Rankless by CCL
2026